Primary cutaneous Langerhans cell sarcoma: A report of four cases and review of the literature

American Journal of Dermatopathology

Volumn 35, Issue 2, 2013, Pages 196-204

  Sagransky, Matthew J ^a   Deng, April C ^b   Magro, Cynthia M ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bone marrow; Histiocytosis; Langerhans cells; Leukemia; Lymph nodes; Lymphoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD83 ANTIGEN; CHLORDANE; CYTARABINE; LANGERIN; LYSOZYME; MYELOPEROXIDASE; PROTEIN S 100; T6 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; BONE MARROW BIOPSY; CANCER MORPHOLOGY; CANCER REGRESSION; CASE REPORT; CELL GROWTH; CLINICAL FEATURE; CONSOLIDATION CHEMOTHERAPY; DISEASE COURSE; EPITHELIOID CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LANGERHANS CELL; LANGERHANS CELL SARCOMA; MALE; PHENOTYPE; PRIORITY JOURNAL; RASH; REVIEW;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; HUMANS; IMMUNOPHENOTYPING; LANGERHANS CELL SARCOMA; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878913093     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182661c0b     Document Type: Review

References (45)

1. Lee JS, Ko GH, Kim HC, et al. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report. J Korean Med Sci. 2006;21: 577-580.
2. Jaffe E, Harris N, Stein H, et al. WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: WHO classification IARC Press; 2001:273-283.
3. Ratei R, Hummel M, Anagnostopoulos I. Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity. Haematologica. 2010;95:1461-1466.
4. Sumida K, Yoshidomi Y, Koga H, et al. Leukemic transformation of Langerhans cell sarcoma. Int J Hematol. 2008;87:527-831.
5. Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433-5439.
6. Weiss LM, Grogan TM, Pileri SA, et al. Langerhans cell sarcoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:283.
7. Jülg BD, Weidner S, Mayr D. Pulmonary manifestation of a langerhans cell sarcoma: case report and review of the literature. Virchows Arch. 2006;448:369-374.
8. Bohn OL, Ruiz-Arguelles G, Navarro L, et al. Cutaneous langerhans cell sarcoma: a case report and review of the literature. Int J Hematol. 2007; 85:116-120.
9. Ferringer T, Banks PM, Metcalf JS. Langerhans cell sarcoma. Am J Dermatopathol. 2006;28:36-39.
10. Egeler RM, Zantinga MA, Coppes MJ, et al. Paul Langerhans Jr (1847-1888): a short life, yet two eponymic legacies. Med Pediatr Oncol. 1994;22:129-132.
11. Silverberg-Sinakin I, Thorbecke GJ, Baer RL, et al. Antigen bearing Langerhans cells in skin, dermal lymphatics, and lymph nodes. Cell Immunol. 1976;25:137-151.
12. Stingl G, Katz SI, Clement L, et al. Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol. 1978;121:2005-2013.
13. Chu T, Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer Suppl. 1994;23:S4-S10.
14. Frishberg Y, Stark B, Mor C, et al. Soft tissue mass as a presenting symptom in Langerhans cell histiocytosis. Pediatr Hematol Oncol. 1988;5:319-324.
15. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
16. Steinman RM, Inaba K. Myeloid dendritic cells. J Leuk Biol. 1999;66: 205-208.
17. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1-29.
18. Lauritzen AF, Ralfkiaer E. Histiocytic sarcomas. Leuk Lymphoma. 1995; 18:73-80.
19. Bonetti F, Knowles DM, Chilosi M, et al. A distinctive cutaneous malignant neoplasm expressing the Langerhans cell phenotype. Cancer. 1985;55:2417-2425.
20. Kawase T, Hamazaki M, Ogura M, et al. CD56/NCAM-positive langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol. 2005;81:323-329.
21. Privratsky JR, Paddock CM, Florey O, et al. Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci. 2011;124:1477-1485.
22. Slone SP, Fleming DR, Buchino JJ. Sinus histiocytosis with massive lymphadenopathy and Langerhans cell histiocytosis express the cellular adhesion molecule CD31. Arch Pathol Lab Med. 2003;127:341-344.
23. Ben-Ezra J, Bailey A, Azumi N, et al. Malignant histiocytosis X: a distinct clinicopathologic entity. Cancer. 1991;68:1050-1060.
24. Deng A, Lee W, Pfau R, et al. Primary cutaneous Langerhans cell sarcoma without Birbeck granules: indeterminate cell sarcoma? J Cutan Pathol. 2008;35:849-854.
25. Liao KT, Rosai J, Dameshek K. Malignant histiocytosis with cutaneous involvement and eosinophilia. Am J Clin Pathol. 1972;57:438-448.
26. Bitran JD, Rowley JD, Plapp F, et al. Chromosomal aneuploidy in a patient with hypereosinophilic syndrome: evidence for a malignant disease. Am J Med. 1977;63:1010-1014.
27. Travis WD, Li CY, Bergstralh EJ, et al. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine. 1988;67:345-368.
28. Bonetii F, Knowles DM, Chilosi M, et al. A distinctive cutaneous malignant neoplasm expressing the Langerhans cell phenotype. Synchronous occurrence with B-chronic lymphocytic leukemia. Cancer. 1985;55:2417-2425.
29. Vasef MA, Zaatari GS, Chan WC, et al. Dendritic cell tumors associated with low-grade B-cell malignancies: report of three cases. Am J Clin Pathol. 1995;104:696-701.
30. Burns BF, Colby TV, Dorfman RF. Langerhans' cell granulomatosis (histiocytosis X) associated with malignant lymphomas. Am J Surg Pathol. 1983:7:529-533.
31. Angstreich GR, Matsui W, Huff CA, et al. Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors. Br J Haematol. 2005;130:373-381.
32. Roddie H, Klammer M, Thomas C, et al. Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia. Br J Haematol. 2006;133:152-157.
33. Negrotto S, Ng KP, Jankowska AM, et al. CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors. Leukemia. 2012;26:244-54.
34. Magro CM, Crowson AN, Mihm MC. The Cutaneous Lymphoid Proliferation. Hoboken, NJ: John Wiley and Sons; 2007: Chapter 23, p 445-449.
35. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32:615-619.
36. Vos JA, Abbondanzo SL, Barekman CL, et al. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Modern Pathol. 2005;18:693-704.
37. Magro CM, Porcu P, Schaefer J, et al. Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol. 2010;63:292-308.
38. Fritsche-Polanz R, Jordan JH, Feix A, et al. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol. 2001;113:357-364.
39. Cammenga J, Horn S, Bergholz U, et al. Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate. Blood. 2005;106:3958-3961.
40. Schnittger S, Kohl TM, Haferlach T, et al. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival. Blood. 2006;107:1791-1799.
41. Fritsche-Polanz R, Fritz M, Huber A, et al. High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V. Mol Oncol. 2010;4:335-346.
42. Egeler RM, Neglia JP, Aricò M, et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:81-85.
43. Ventura F, Pereira T, da Luz Duarte M, et al. Indeterminate cell histiocytosis in association with acute myeloid leukemia. Dermatol Res Pract. 2010;2010:569345.
44. Ghosn MG, Haddad AC, Nassar MN, et al. Acute myeloid leukemia and Langerhans' cell histiocytosis: multiple theories for an unusual presentation. Leuk Res. 2010;34:406-408.
45. Nakayama M, Takahashi K, Hori M, et al. Langerhans cell sarcoma of the cervical lymph node: a case report and literature review. Auris Nasus Larynx. 2010;37:750-753.